Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Eliezer Liberman"'
Autor:
Ezra Bernstein, Shahar Lev-Ari, Shiran Shapira, Ari Leshno, Udi Sommer, Humaid Al-Shamsi, Meital Shaked, Ori Segal, Lior Galazan, Mori Hay-Levy, Miri Sror, Amira Harlap-Gat, Michael Peer, Menachem Moshkowitz, Ido Wolf, Eliezer Liberman, Gil Shenberg, Eyal Gur, Hanoch Elran, Gustavo Melinger, Jacob Mashiah, Ofer Isakov, Elad Zrifin, Nathan Gluck, Roy Dekel, Shlomi Kleinman, Galit Aviram, Arye Blachar, Ada Kessler, Orit Golan, Ravit Geva, Ofer Yossepowitch, Alfred I. Neugut, Nadir Arber
Publikováno v:
Journal of Clinical Oncology. 41:2503-2510
PURPOSE Cancer is the second leading cause of death globally. However, by implementing evidence-based prevention strategies, 30%-50% of cancers can be detected early with improved outcomes. At the integrated cancer prevention center (ICPC), we aimed
Autor:
Sarah Kraus, Lior Galazan, Nadir Arber, Serhan Moanis, Miri Sror, Maayan David, Shiran Shapira, Doran Avivi, Menachem Moshkowitz, Eliezer Liberman, Nitsan Maharshak, Ari Leshno, Amira Harlap-Gat
Publikováno v:
International Journal of Cancer. 138:1361-1367
This study is the first attempt to evaluate the association between the APC I1307K variant and overall cancer risk. It is unique in both its large sample size and in the reliability of data in the control group. The findings described in this article
Autor:
Arye Blachar, Ari Leshno, Hanoch Elran, Meital Shaked, Orit Golan, Ezra Bernstein, Ravit Geva, Ada Kessler, Lior Galazan, Nadir Arber, Miri Sror, Galit Aviram, Moran Steiner, Eliezer Liberman, Eyal Gur, Ido Wolf, Amira Harlap-Gat, Shiran Shapira, Shlomi Kleinman, Ofer Isakov
Publikováno v:
Journal of Clinical Oncology. 37:e13069-e13069
e13069 Background: Cancer is the second leading cause of death globally, and was responsible for ~9.6 million deaths in 2018. Importantly, between 30–50% of cancers can be prevented by avoiding risk factors and implementing existing evidence-based
Autor:
Mati Ormianer, Olivia Rosenfeld, Sarah Kraus, Ariel J. Jaffa, Inna Naumov, Fanny Sperber, Arye Blachar, Ilan Aroch, Diana Kazanov, Eliezer Liberman, Tal Sella, Eyal Gur, Miki Bloch, Vadim Reiser, Amira Gat-Charlap, Lior Galazan, Nadir Arber, Shlomi Kleinman, Roy Inbar, Ben Boursi, Menachem Moshkowitz, Ehud Miller, Nicola J. Mabjeesh
Publikováno v:
European Journal of Internal Medicine. 24:245-249
Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality.We aimed to describe the experience of an integrated cancer prevention center in screening an asymptomatic population for the pr
Autor:
Z. Meiner, Eugene Leibovitz, Eliezer Liberman, Shlomo Berliner, Nadir Arber, Deborah L. Seltzer
Publikováno v:
Acta Neurologica Scandinavica. 96:123-126
OBJECTIVE White blood cells might have a pathogenetic role in ischemic vascular conditions. Several studies have suggested that increased adhesiveness of these cells could contribute to such a damage. The present study was undertaken in order to exam
Publikováno v:
Clinical Cancer Research. 13:6807-6815
Purpose: Cyclooxygenase-2 inhibitor (celecoxib, Pfizer) is a promising chemopreventive agent, yet its long-term use may be limited due to increased cardiovascular toxicity. This study was aimed to identify genes and pathways involved in colorectal tu
Autor:
Ari, Leshno, Shiran, Shapira, Eliezer, Liberman, Sarah, Kraus, Miri, Sror, Amira, Harlap-Gat, Doran, Avivi, Lior, Galazan, Maayan, David, Nitsan, Maharshak, Serhan, Moanis, Nadir, Arber, Menachem, Moshkowitz
Publikováno v:
International journal of cancer. 138(6)
This study is the first attempt to evaluate the association between the APC I1307K variant and overall cancer risk. It is unique in both its large sample size and in the reliability of data in the control group. The findings described in this article
Autor:
Diana Kazanov, Nadir Arber, Hadas Dvory-Sobol, Eliezer Liberman, Moshe Leshno, Shlomo Birkenfeld, Pauline Luk, Benny Bulvik
Publikováno v:
International Journal of Cancer. 118:11-16
New selective cyclooxygenase-2 inhibitors offer the benefit of cancer protection with less gastrointestinal toxicity associated with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). We hypothesize that MF tricyclic and sulindac can retard
Autor:
Efrat Choen-Noyman, Ludmila Strier, Talya Kunik, Varda Deutsch, Hadas Dvory-Sobol, Marjorie Pick, Eliezer Liberman, Diana Kazanov, Nadir Arber
Publikováno v:
Clinical Cancer Research. 10:267-271
Purpose: Nonsteroidal anti-inflammatory drugs reduce the risk of colorectal cancer. The cyclooxygenase (COX) pathway of arachidonic acid metabolism is an important target for nonsteroidal anti-inflammatory drugs. Increased expression of COX-2 was rec
Autor:
Diana Kazanov, Nadir Arber, Eliezer Liberman, Talya Kunik, Olga Kolker, Marjorie Pick, Varda Deutsch, Hadas Dvory-Sobol, Loudmilla Strier, Itzhak Shapira
Publikováno v:
Digestive Diseases and Sciences. 48:1251-1261
Cyclin D1 plays an important role in the multi-step process of gastrointestinal tumorigenesis. We hypothesize that normal enterocytes over-expressing Cyclin D1 will demonstrate a transformed phenotype. The nontumorigenic intestinal epithelial cell li